Skip to main content
Clinical Trials/NCT07659886
NCT07659886Not yet recruitingPhase 3

Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures

Atlantic Health System1 site in 1 country100 target enrollmentStarted: June 10, 2026Last updated:
Interventions

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
100
Locations
1

Study Overview

Brief Summary

To evaluate the feasibility, safety, and potential efficacy of applying vancomycin powder locally to open fractures in the emergency department prior to definitive surgical intervention.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Participants aged 18 years or older presenting to the Emergency Department with Gustilo-Anderson Type I, II, or III open fractures.

Exclusion Criteria

  • Known allergy to vancomycin
  • Ballistic open fractures
  • Pregnancy
  • Currently breastfeeding
  • Age younger than 18 years.

Arms & Interventions

Emergency Department Vancomycin Powder

Experimental

Patients receive 1 gram topical vancomycin powder applied to the open fracture wound in the Emergency Department in addition to standard open fracture management.

Intervention: Vancomycin (VAN) treatment (Drug)

Standard Open Fracture Care

Active Comparator

Patients receive standard open fracture management without Emergency Department (ED) vancomycin powder.

Intervention: Standard Open Fracture Care (Other)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kristen De Wilde

Resident physician

Atlantic Health System

Study Sites (1)

Loading locations...

Similar Trials